Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Adaptive Biotechnologies (ADPT)
at www.tipranks.com (Thu, 5-Nov 9:10 AM)
Precigen GAAP EPS of $0.08 in-line, revenue of $74.1M beats by $2.54M
at seekingalpha.com (Wed, 4-Nov 5:05 PM)
at seekingalpha.com (Tue, 3-Nov 11:17 AM)
Precigen’s Commercial Momentum Supports Reiterated Buy Rating; $18 Price Target Maintained
at www.tipranks.com (Mon, 2-Nov 1:05 PM)
Precigen craters on Inovio Voceryq immunotherapy approval
at seekingalpha.com (Mon, 2-Nov 11:14 AM)
Market Chameleon (Mon, 21-Sep 7:34 AM)
